Viking Therapeutics, Inc.

• Viking Therapeutics begins study of oral VK2735 for obesity
  Clinical Trials Arena · 07 Oct 2026
• Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity
  PR Newswire · 06 Oct 2026
• Should You Buy Viking Therapeutics Stock While It Trades Below Its $35 Offering Price?
  The Motley Fool · 02 Oct 2026
• Form 8K Viking Therapeutics Inc For: 28 September By Investing.com
  Investing.com India · 29 Sep 2026
• Eli Lilly Stock Barely Moved Following Viking Therapeutics' Impressive Clinical Results. Here's Why.
  The Motley Fool · 29 Sep 2026
• Viking Therapeutics (VKTX) Closes Upsized Stock and 2.00% Convertible Notes Offerings, ~$575M Gross
  TradingView · 28 Sep 2026
• 3 Numbers From Viking Therapeutics' Weight-Loss Drug Trial That Have Wall Street Buzzing
  The Motley Fool · 27 Sep 2026
• Viking Therapeutics Soared After Its Latest GLP-1 Data. Is It Too Late to Buy?
  The Motley Fool · 25 Sep 2026
• Form 424B5 Viking Therapeutics Inc For: 25 September
  Investing.com India · 25 Sep 2026
• Viking Therapeutics drops 15% after $500M stock offering; Jaguar Health falls 25% without news.
  Pluang · 24 Sep 2026
• Why is Viking Therapeutics stock tumbling today?
  Investing.com · 24 Sep 2026
• Here's Why Viking Therapeutics Shares Slumped Today
  The Motley Fool · 24 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →